CYTO365
Micael Törnblom is a seasoned entrepreneur and aviation professional with a diverse background in both the medical technology and airline sectors. As the CEO and Founder of CYTO365 AB since November 2013, Törnblom has led the development of the RondelO medical stopcock, aimed at addressing drug incompatibility in infusion treatments, particularly in oncology. Holding the title of CEO and Founder at Flightlevel Holding since February 2012, Törnblom previously served as First Officer at Norwegian from January 2012 to April 2020. Törnblom founded HittaFlyget.se in June 2008, a platform that consolidates Swedish domestic airliner destinations. Additionally, Törnblom's experience includes serving as an Airline Pilot at Svenska direktflyg and holding various roles in sales coaching. Törnblom's educational credentials encompass a Master's degree in Mechanical Engineering, a Candidate degree in Airline Management, and specialized training in oncology and flight mechanics from reputable institutions.
This person is not in any teams
This person is not in any offices
CYTO365
CYTO365 is the manufacturer of RondelO multi inlet stopcock, which is sold as a component aimed to be integrated into IV-set to combat Drug Incompatibility due to parallel infusion.